Search All UT System Experts

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

Ajai Chari, Robert F. Cornell, Cristina Gasparetto, Chatchada Karanes, Jeffrey V. Matous, Ruben Niesvizky, Matthew Lunning, Saad Z. Usmani, Larry D. Anderson, Saurabh Chhabra, Saulius Girnius, Chaim Shustik, Robert Stuart, Yihua Lee, Zeena Salman, Emily Liu, Jason Valent

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences